MET and lung adenocarcinoma: Figure 3E demonstrates that high MET-u1 expression is significantly associated with poor prognosis in lung adenocarcinoma (LUAD) and pancreatic adenocarcinoma (PAAD), highlighting the potential prognostic value of MET-u1 in these cancer types.